Delivering our partners preclinical discoveries through world class capabilities,
directed by teams with a reputation for collaboration and scientific excellence
Magical Power of QM
To Empower Organic Syntheses
With powerful workstations, state of the art software, and our expertise on reaction QM analyses, real-time incorporations of such calculations in prospective analyses become routines in Research Service Division.
Drugging the Undruggable
Leveraging the Right Screening Methods for Challenging Targets
“In the past, thousands of proteins were considered undruggable. This meant that previous efforts to develop a drug against them failed. Today, the combination of novel chemical modalities and advanced technical approaches has resulted in new clinical candidates for previously undruggable targets.”
Women in Science
Breaking the glass ceiling
We spoke to four leaders of research and business operations at WuXi AppTec to discuss their views on Women in Science in the 21st century.
Richard Lerner, M.D.
A Conversation with Richard Lerner: DELopen Promotes Worldwide Academic Research Using DNA-Encoded Libraries, Far More Than Just a Numbers Game.
Insights from target to IND
WuXi AppTec webinar series highlighting novel scientific, therapeutic-focused and industry insights from key subject matter experts.
Partner of ‘Target-to-Hit’ discovery
WuXi AppTec HitS Unit provides a one-stop Target-to-Hit services that enable companies in the pharmaceuticals, biotech and academics worldwide to seek premium drug discovery.
International Conference on Neuropharmacology and Biopharmaceutics 2020
September 24-25, 2020
World Conference on Cancer Biology, Immuno Oncology and Drug Discovery
October 19-20, 2020